Gender differences are increasingly recognized in cardiology. It is also well known that women have higher complications and a higher mortality related to coronary procedures. In arrhythmias, gender-specific variations in the electrophysiological structure of the heart or hormonal effects may explain some of the gender differences. The aim of this study was to evaluate gender differences according to their risk factors, indications and modes of pacing. A total of 267 patients who had pacemaker implantation for bradyarrhythmia indications were enrolled in our study. A pre-designed questionnaire was filled to record their baseline characteristics, clinical indications and mode of pacing. Out of 267 patients 190 were male and 77 were female. Data was analyzed with SPSS 16.0 software (SPSS, Chicago, IL, USA) The pacemaker implantation requirement was 31% significantly lower among males compared with females who were hypertensive (RR=0.69, 95%CI=0.58-0.82, p=0.0001) and 1.57 times (RR=1.57, 95%CI=1.32-1.87, p=0.0001) significantly higher among male patients than females who were the tobacco user in any form. The single chamber requirement was 1.41 times significantly (RR=1.41, 95%CI=1.16-1.71, p=0.0001) higher in males than females. The risk analysis showed that complete heart blockage (p= 0.02) and sick sinus syndrome (p= 0.01) were significantly higher in males as compared with females. In conclusion male patients had more CHB, sick sinus syndrome and syncope as primary pacemaker indication, compared with female patients. Smoking was the most prominent risk factor in male and hypertension in female and most importantly there were significant gender differences in indications leading to pacing.
INTRODUCTION
Cardiac arrhythmia encompasses a large and heterogeneous group of electrical abnormalities of the heart, with or without underlying structural heart disease. Cardiac arrhythmias can be innocuous, can predispose to the development of potentially lethal stroke or embolus, or can present emergently with a life-threatening condition that may result in sudden cardiac death (SCD), one of the most common causes of death in the developed countries (Tester and Ackerman, 2011) Arrhythmias resulting in bradycardia or tachycardia can be thought of as specific disorders of each of these components (Olgin and Zipes, 2011) . Bradyarrhythmia is a general term that describes a number of conditions in which the heart beats at an unusually slow rate (fewer than 50 to 60 beats per minute). However, electrical impulses may be slowed, delayed, or blocked .
The study was carried out in accordance with the ethical standards of the university (Ethical Clearance Certificate No. 63ECM-IIB/2). The patients who were diagnosed with bradyarrhythmia and related conduction disorders and had permanent pacemaker implantation in situ were enrolled for the study. Inclusion criteria of the patients were-a) Subjects of both sexes above 18 years presenting with bradyarrhythmia and conduction disorder. b) Subjects of both sexes having pacemaker implanted previously for bradyarrhythmias. c) Subjects willing to give written informed consent. Exclusion criteria includeda) Subjects of both sexes below 18 years. b) Subjects of both sexes, not having indication of pacemaker implantation. c) Not willing to give written informed consent.
A detailed questionnaire was developed with the help of a physician in the institute. The questionnaire was filled with the help of physician to record sex, age, history of tobacco consumption, history of hypertension, diabetes, history of other complications and types of pacemaker implanted. Heart rate and blood pressure was also estimated at the time of the enrolment. Pacemaker details, complication rates and modes of pacing were also recorded. A written informed consent was obtained from every patient. Blood pressure was measured with the patients in a sitting position after a 5-minute rest with use of a mercury sphygmomanometer and read to the nearest 2 mm Hg. Subjects were classified as having hypertension if they were receiving drug treatment for hypertension or had systolic blood pressure of at least 160 mm Hg or diastolic blood pressure of at least 95 mm Hg. Other cardiovascular risk factors like diabetes were defined as follows: if the patient was treated for diabetes or was previously diagnosed by a primary care physician according to guidelines.
Patients who were taking tobacco in any form (bidi, cigarette, khaini, gul, gutkha, hukka, pan etc.) were considered in the tobacco consumption category.
Statistical analysis
The SPSS software (Chicago, Illinois; Version 15.0) was used for all statistical analyses. A P-value of <0.05 was considered significant. Data are presented as percentages for discrete variables and as mean ± standard deviation and/or median for continuous variables. Differences in baseline characteristics between age groups were compared using unpaired t-test and Fisher's exact test.
RESULTS
Out of the total 267 patients studied, there were 190 males and 77 females with previously implanted pacemaker. No significant difference (p>0.05) in the age was found between male (63.84±12.38) and female (62.16±11.37) patients. Among hypertensive subjects, the pacemaker implantation requirement was 31% significantly lower among males as compared with females (RR = 0.69, 95% CI = 0.58-0.82, p<0.001). However, there was no association between diabetes status and gender in the requirement of pacemaker (p >0.05). Amongst those consuming tobacco in any form, pacemaker requirement was 1.57 times (RR=1.57, 95%CI=1.32-1.87, p<0.001) significantly higher among male patients than females ( Table-1 ).
The single chamber pacemaker requirement was 84.2% among males and 59.7% in females. However, dual chamber pacemaker requirement was 15.8% in males and 40.3% in females. The single chamber requirement was 1.41 times (RR=1.41, 95% CI=1.16-1.71, p<0.001) significantly higher in males than females (Table-2 ).
The percentage of CHB was higher among male (44.7%) patients than female (40.3%) patients. The risk analysis showed that CHB was 2.74 times significantly higher in males compared with females (RR=2.74, 95%CI= 1.12-6.74, p=0.02). SSS was 8 times higher among males than in females (RR=8.00, 95% CI=1.50-42.65, p=0.01) and this was statistically significant. The percentage of syncope was 6.8% in males and 3.9% in females, however, the difference was nearly significant (p=0.05). Other symptoms were not found to be associated (p>0.05) with gender ( Table-3 ).
Multivariate analysis revealed that hypertension (p<0.001), smoking (p=0.001), pacing indications (p=0.001), SSS symptoms (p=0.003) and syncope were significantly associated with gender and the requirement of pacemaker (Table-4). 
DISCUSSION
Our data showed significant differences in risk factors, complications and modes of pacing between both the genders. Primary complications leading to pacing in males had more CHB, syncope and sick sinus syndrome as compared to females. This distribution can also be found in the Swedish pacemaker registry as well (Swedish Pacemaker Register, 2009 ). According to age, women were significantly less likely to receive a dual-chamber device with an age of 80 years or above with an indication of either AV block or sick sinus syndrome (Batz and Irnich, 1995; Batz and Irnich,1997; Schuppel et al., 1998) . In our study women were significantly less likely to receive a single pacing (p<0.001). This result is inconsistent with the study of Lamas et al., (1995) , in which they showed that men received proportionally more dual chamber pacemaker than women, even after adjustment for demographic and clinical characteristics (Lamas et al., 1995) . This result is different from our study in which women were significantly less likely to receive a single pacing. The value is significant in men (p value<0.001). Very scanty literature is found of such a study related to pacing in bradyarrhythmia and conduction disorder. Similar work has been done from the German Pacemaker registry in the early 1990s which showed that men received more pacemakers than women and that DDD and rateresponsive systems were used more frequently in men (Batz and Irnich, 1995; Batz and Irnich,1997; Schuppel et al., 1998 ).
These differences are more accentuated in low volume centers. On the contrary, no gender differences for pacemaker implantation have been documented in an Italian study (Boccia et al., 2005) . A study from The Netherlands evaluating 33,564 patients demonstrated no gender differences in pacemaker selection, but a considerable drop in dual-chamber implantation with increasing age (Roeters et al., 2000) . Another single centre study evaluating 259 patients found no significant difference in pacemaker mode selection between male and female patients (Veerareddy et al., 2007) . However, in this study, the patient group was considerably younger with a mean age of 61 years, when compared with our patient cohort with a mean age of 62 years. In our study smoking has emerged as one of the major risk factors for pacemaker patients in both the groups. We found that it causes adverse effect on the cardiac conduction system. It has been proved that consuming tobacco in any form (smoke and smokeless tobacco) cause adverse effect on health including cancer of oral cavity, oral soft tissue lesion, gum recession and nicotine addiction (Ferrence et al.., 2000; Hatsukami and Severson, 1999; Hatsukami et al.., 2004; Winn et al.., 1981) but in one study there was association between smokeless tobacco use and cardiovascular disease (Bolinder et al., 1994 ) although this has not been a consistent finding (Accortt et al.., 2002; Asplund, 2003) . The adverse effects of smoking on vascular function have been examined in human subjects. These studies have shown that acute and chronic cigarette smoking impairs nitric oxide synthase (Zeiher et al., 1995; Silvestrini et al., 1996; Heitzer et al., 1996) . However, a consensus of the causal relationship between electro physical disorders of the heart and consumption of smoking and smokeless tobacco has not yet been reached. What has been known is the acute hypertensive effect observed in smokeless tobacco users (Westman, 1995) .
CONCLUSION
The present study concludes that there were significant gender differences in indications leading to pacing. Concerning complications leading to pacing in both the sexes, male patients had more CHB, sick sinus syndrome and syncope as primary pacemaker indication, compared with female patients. Primary complications leading to pacing in males had more CHB, syncope and sick sinus syndrome as compared to females. This distribution can also be found in the Swedish pacemaker registry as well. Also smoking emerged as the most prominent risk factor in male and hypertension in female.
